Bentham Science Logo

Track Your Manuscript:


Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 20, 4 Issues, 2020
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Drug Targets - Cardiovascular & Hematological Disorders, Volume 5 - Number 5

Erythropoietin in Heart Failure and Other Cardiovascular Diseases: Hematopoietic and Pleiotropic Effects

, 5(5): 355 - 375

Antonis S. Manolis, Stylianos Tzeis, Kostas Triantafyllou, John Michaelidis, Ioannis Pyrros, Nikolaos Sakellaris, Athanasios Kranidis and Helen Melita


DOI: 10.2174/156800605774370326





Drug Therapy in Brugada Syndrome

, 5(5): 409 - 417

Manlio F. Marquez, Gabriel Salica, Antonio G. Hermosillo, Gustavo Pastelin and Manuel Cardenas


DOI: 10.2174/156800605774370353




Editor-in-Chief

Garry X. Shen
University of Manitoba
Winnipeg, MB
(Canada)

Biography
View Full Editorial Board

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.46

New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Advertisement

STATISTICS AND DATA PRESENTATIONCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog